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We examine the Chlamydia trachomatis (Ct) immunopathogenesis on the basis of the complex interaction between host immune
response and virulence microorganism factors. Ct infection can be asymptomatic or may produce an inﬂammation elicited and
preserved by reinfections or persistent infections. We discuss the host polymorphisms that, with their anti- or proinﬂammatory
eﬀects, determine the course of the disease. We also took into account the inﬂammation process following the Chlamydia
illness and the role of both CD4 cells producing IFN-γ and CD8 cells with their cytokines production. The crucial role of
Ct-hsp60 and the double activity (either damaging or preserving from some kinds of tumors) of anti-Ct-hsp60 antibodies are
considered.
1.Introduction
Chlamydia trachomatis (Ct) is an obligate intracellular
bacteria, and it results to be the most common sexually
transmitted disease that, other than being asymptomatic and
therefore unrecognized and untreated, promotes an acute or
chronic inﬂammation causing tissue damage, pelvic inﬂam-
matory disease (PID), infertility, and ectopic pregnancy.
Latest international estimates show that around 92
million new cases of Chlamydia infection occur every year
[1]. Most of Chlamydia goes undiagnosed, and its infection
is often asymptomatic and can persist for long periods.
Studies on the natural course of untreated C. trachomatis
lower genital tract infections in women show spontaneous
clearance rates of 30% in the ﬁrst weeks to months, 50% in
1 year, 80% in 2 years, and 94% in 4 years [2]. Although this
is often the case, chlamydial infection induces an intense and
chronic inﬂammation.
The clearance of the microorganisms depends on both
a normal immune response and an antibiotic treatment.
However, some women are not able to clear the pathogen
adequately and become asymptomatic. Repeated infections
can be even more damaging for women, because they cause
serious sequelae for the genital apparatus.
The principal ﬁndings concerning Chlamydia trachoma-
tis immunopathogenesis include the following points:
(1) The Normal Immune Response to Infections. The host
immune response to infection and how this relates to disease
is still not completely understood. The immune response
to Ct in infected women is involved in both immunity
and pathology. A strong adaptive immune response is able
to develop and increase the chlamydial virulence and to
worsen the clinical course of the illness. This response is a
key mechanism involved in controlling or eliminating the
infection having a double-edged nature which can be both
protective and tissue damaging.
(2) The Host Susceptibility. Host response greatly aﬀects
the outcome of Ct disease inﬂuencing and determining the
pathology. The host response is not able to contrast or
control the Ct infection. In fact, if the microorganism is not
adequately treated, it remains for long periods in the infected
subjects [2]. In other words, host response contributes to
determine the microorganism pathology. Indeed, not only
thecharacteristicsofthepathogen,butalsohostgeneticsplay
an important role in determining susceptibility to infections
and severity of disease. In recent years, the importance of2 ISRN Obstetrics and Gynecology
host genetic polymorphisms in Ct-related pathologies has
been demonstrated [3–6].
(3) The Heat Shock Protein (hsp60). Ct-hsp60 has been
shown to be an important target for the immune response
linked to complications [7]. Antibodies to Ct-hsp60 have
been suggestedas markers of chronic inﬂammation and may,
therefore, be good predictors for the risk of tubal pathology
[8]. The ﬁndings of elevated human serological responses
to Ct-hsp60 in individuals with severe diseases have been
conﬁrmed for genital tract illness as well as for trachoma [9].
The precise role of Ct-hsp60 (similar to human-hsp60) and
anti-Ct-hsp60 antibody is still unclear.
Granted that chlamydial infection is based on the above
points, our paper will address the immunopathology, the
host susceptibility, and the crucial role of Ct-hsp60 in the
pathogenesis.
ChlamidiatrachomatisandImmunopathogenesis. ChronicCt
infection is characterized by genital tract inﬂammation and
mucosa inﬁltration of the full range of inﬂammatory cell
types with a predominant amount of lymphocytes. However,
and this is uncommon when considering chronic inﬂam-
mation, there is a consistent neutrophilic component [5, 6].
The rate of inﬂammation and the consequent development
of disease is known to be multifactorial: indeed, it involves
the virulence of diﬀerent strains of Ct, the environmental
cofactors and the host immune response. Ct infection
strongly induces and maintains both innate and acquired
immune response. However, rarely the immune response to
Ct results in clearance of the infection. This is due to the
ability of Ct of evading the host’s immune system [1, 3–6].
2. InnateImmune System
Innateimmunesystemisageneral,nonspeciﬁcsystemwhich
is the ﬁrst line of defense against pathogens. Ct infects the
columnar epithelial cells of the endocervix of women. At the
site of infection, an intense inﬂammation occurs attracting
macrophages, neutrophils, dendritic cells (DCs), natural
killer (NK) cells, T-lymphocytes, B cells, and so forth. After
infection, epithelial cells produce various pro-inﬂammatory
mediators including CCL5, CXCL16, CXCL 10, CXCL 1,
IL-1α, IL-8, IL-12, IL-6, GM-CSF (granulocyte-macrophage
colony stimulating factor), TNF (tumor necrosis factor), and
GROa (growth-related oncogene) that induce and augment
the cellular inﬂammatory response thus stimulating direct
damage to the tissues and producing an increased expression
of endothelial adhesion molecule that helps the attraction of
immune cells [5]. Resident macrophages also contribute to
early release of cytokines and chemokines. Both epithelial
cells and circulating cells of the innate immune system
possess receptors called pattern of recognitions (PRRs).
The two most important families of PRRs are the Toll-like
receptors (TLRs) and the nucleotide-binding oligomeriza-
tion domain proteins (NODs). These receptors recognize
and bind particular molecular antigens of the pathogen
(PAMPs—pathogen-associated molecular patterns). PRRs of
epithelial cells or of circulating cells are found in the extra-
cellular, in the intracellular compartments (NOD), or bound
to cell surface (TLR). Binding of NOD or TLR to PAMPs
induces a series of reactions, which lead to the activation
of the NF-KB (Nuclear factor) signal transduction cascade
that binds to the nuclear DNA promoting and increasing
the production of proinﬂammatory cytokines (Figure 1).
Infected epithelial cells also release matrix metalloproteases
(MMPs) that contribute to cell damage and scar formation.
Neutrophils, NK cells and monocytes are recruited in
the infected tissue. MMPs and elastase are also produced by
neutrophils thus contributing to pathology [5].
2.1. Toll-Like Receptors (TLRs) and (Nucleotide-Binding Oli-
gomerization Domains) NODs. TLRs may be involved in
the pathology of STIs (sexually transmitted infections).
They act as pathogen-recognition receptors that enable cells
to recognize chlamydial structural elements. In Chlamydia
pathogenesis,TLR2andTLR4aremostlyinvolvedwithTLR2
required for IL-8 secretion. Activation of these receptors
was dependent on live, replicating bacteria, because it has
been demonstrated [10] that the treatment of infected cells
with antibiotics or UV eliminated the induction of IL-
8 secretion suggesting that TLR2 is actively engaged in
signalling from this intracellular location. A dominant role
forTLR2comparedwithTLR4hasbeenconﬁrmedatleastin
therecognitionandresponsetoChlamydiamuridaruminthe
murine genital tract [11]. TLR2 is recruited to intracellular
Chlamydiae and is required for cellular activation (deter-
mined by IL-8 measurement) during infection. In human
cells, TLR2 is the PRR for the C. trachomatis component
peptidoglycan, and it is mainly expressed in the tubes and
cervix. On the contrary, TLR4 is the PRR for Ct components
lipopolysaccharide (LPS) and heat shock protein, and it is
mainly expressed in the tubes and endometrium and less
or not at all in the endocervix [3, 6]. Clamydial heat shock
protein 60 acts via TLR4 to activate NF-KB and increase IL-8
secretion. TLR1, TLR3, TLR5, and TLR6 are also present in
thehumanfemalegenitaltract,buttheydonotrecognizeCt-
PAMPs. This suggests that the above TLRs may play a role in
the host defense against non-Ct infections [12, 13].
NOD proteins are intracellular PPRs. They include two
subclasses (NOD1 and NOD2) and are able to recognize
intracytoplasmatic bacterial PAMPS such as LPS and pepti-
doglycans.BecauseCtisanintracellularpathogencontaining
LPS and peptidoglycan, the role of intracellular NOD in
recognition of C. trachomatis is crucial [14]. Binding of
an NOD to its PAMP also activates the NF-KB signal
transduction cascade, which initiates the immune response.
It is hypothesized that the risk of late sequelae increases
with the number of genetic variations in NODS or TLRs
[3]. Carrying multiple genetic variations in PRRs plays a
role in the development of C. trachomatis-associated tubal
pathology. den Hartog et al. [3] showed a higher risk in
carriers of at least two genetic variations (73%) as compared
with carriers of less than two variations (33%). Therefore,
carrying multiple genetic variations rather than a single one
is determinant for the risk of late sequelae. In this context,
the nucleotide polymorphisms in PRRs (TLRs and NODs)
in women with chlamydial infection suggest that patternISRN Obstetrics and Gynecology 3
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Figure 1: Modiﬁed from den Hartog et al. 2006 [3]. The innate immune response starts by binding of pathogen-associated molecular
patterns (PAMPs) to the cells receptors (PRRs). This activates the nuclear factor (NF)-κB that binds to speciﬁc DNA sequences in the
nucleus, inducing the production of proinﬂammatory cytokines.
Table 1: Presence of Toll-like receptors (TLRs) and nucleotide-
binding oligomerization domains (NODs) in the genital tract.
PRRs PAMPs
Presence in genital tract
In vivo In vitro
TLR2 Peptidoglycan + +
TLR4 LPS and hsp + +
TLR9 Bacterial DNA NT +
NOD1 Peptidoglycan NT NT
NOD2 Peptidoglycan LPS NT NT
Modiﬁed from den Hartog et al. 2006 [3].
Legenda: hsp: heat shock protein; LPS: lipopolysaccharide; NT: not tested;
PAMPs: pathogen-associated molecular patterns; PRRs: pattern recognition
receptors.
recognition receptors are involved in the progression of the
infection [6]. The presence of TLRs and NODs in the genital
tract is reported in Table 1.
2.2. NAP (Natural Antimicrobial Peptides and Defensins).
The immune innate system produces other key mediators
such as the NAPs (natural antimicrobials peptides) and the
defensins both playing an important role in the pathogen
elimination. NAPs, which include secretory leukocyte pro-
tease inhibitors (SLPI) and elaﬁn, are released at epithelial
surfaces and disrupt the membranes of many microbial
pathogens [15].
SLPI and elaﬁn are able to contrast the action of MMPs
(metalloproteases), thus contributing to the prevention of
the damage due to an over production of proteases by
epithelial cells and neutrophils. SLPI inhibits the neutrophil
elastase, the trypsin, and other damaging products; elaﬁn is
mainly directed against neutrophil elastase and proteinase 3
[16]. SLPI and elaﬁn are expressed in the femalegenital tract.
The eﬀect of NAPs and especially SLPI are contrasted by
anti-SLPI antibody in the endometrial epithelial cells. These
data suggest that SLPI is included in the endometrial and
Fallopian tube epithelium innate immune response [17, 18].
SLPI and elaﬁn show a variety of anti-inﬂammatory eﬀects
even in other tissues probably due to their antiproteinase or
antibacterial eﬀects.
Leucocytes and epithelial cells produce a variety of
human defensins (human β-defensins HBD and α defensins-
HD5) that result to be present in the endometrial epithelium
[19]. Being present at key sites, they have been reported to be
involved in the innate immune response during pregnancy
in order to maintain sterile the uterus environment [20].
Innate immune system competence is of critical importance
in preventing microbial penetration [6]. In fact, in women’s
genital tract, we can distinguish the sterile upper tract
(endometrium and Fallopian tube) and the nonsterile lower
tract (vagina and cervix). They have a compartmentalized
innateimmuneresponse:invaginaandendocervix,although
they are colonized by a variety of commensal bacteria,
infections are relatively uncommon suggesting eﬀective con-
tainment or eﬃcient elimination of pathogens. Infection of
the endometrium and tube occurs when the microorganism
breaches the cervical barrier and ascends to the upper genital
tract.Knowinginadvancetheinnateimmunityinthegenital
tract is decisive, because it will inform us on the interventive
strategies to protect women against disease and eventually to
treat the infection [21].
3. AcquiredImmuneSystem
The acquired (or adaptative) immune system is a speciﬁc
system that develops after the ﬁrst contact with a pathogen.4 ISRN Obstetrics and Gynecology
Macrophages and both dendritic cells (plasmacytoid DCs
and myeloid DCs) are able to express on their surface bac-
terial antigens bound to major histocompatibility complex
and to serve as antigen presenting cells (APC), which is
critical for the activation of the adaptative immune system.
Plasmacytoid dendritic cells (pDCs) were reported to be
mainly recruited in women with inﬂammation in the genital
tract or in those having fertility disorders [1]. The response
toAPCisstrongerthaninnateimmuneresponseofepithelial
or circulating cells, inducing a more marked inﬂammatory
response. A Ct infection evokes a vigorous local and systemic
acquired humoral and cell-mediated response.
3.1.HumoralImmunity. Inthehumoralarm,B-lymphocytes
are activated by APC and develop into plasmacells which are
able to produce antibodies such as Immunoglobulins (Igs).
Thedominantimmunoglobulinisotypefoundinthecer-
vicovaginal ﬂuid of the female genital tract is IgG rather than
secretory IgA. These antibodies can neutralize the antigen
or directly destroy the pathogen inactivating extracellular
elementary bodies (EBs) [5]. It has been shown [1] that Ct-
speciﬁc antibodies do not generally correlate with resolution
of infection in individuals, but they are correlated with
severe sequelae such as tubal infertility, ectopic pregnant,
and PID. Moreover B-lymphocytes can serve as APCs for
T-lymphocytes. As a consequence, although antibodies can
help in clearance of infection, their major role is in the
enhancement of Th1 activation [3].
In female, the prevalence of IgG and IgA antibodies
towards Ct-MOMP antigen (major outer membrane pro-
tein) is mainly found in subjects with primary chlamydial
infections, whereas the presence of antibodies against Ct-
hsp60 and Ct-hsp10 is signiﬁcantly higher in patients with
recurrent or persistent infections. The dominant Ct-hsp60
and Ct-hsp10 antibodies are found in all the situations,
where major fertility disorders are reported [21–24].
3.2. Cell-Mediated Immunity. In the cell-mediated arm, T-
lymphocytes are activated by APCs (cells of innate immune
system or B lymphocytes). Most T-lymphocytes are T-helper
cells (Th). The Th cells can be subdivided in Th1 and Th2
subclasses both producing proinﬂammatory cytokines. The
mononuclear cells produce IL-12 and induce the diﬀerentia-
tionofna¨ ıveT-cellintoT-helper1(Th1).Th1cellssecreteIL-
12, IFN-γ, and IL-2 which support the cell-mediated system
increasing the level of inﬂammatory processes, whereas Th2
subclass produces IL-4, IL-5, IL-6, and IL-10 which support
the humoral system. The relative contributions of the two
classes of Th-cells determine whether the cell-mediated or
the humoral immunity is predominant.
Th1-type responses (producing IFN-γ) play a role in the
resolution of infection, whereas Th2-type responses involved
in the humoral immunity is crucial for scarring [4]. In fact,
patients with severe scarring are found to show high levels
of antichlamydial antibody. Holland et al. [25]r e p o r t e d
that patients with more severe diseases often produced Th2-
type patterns of cytokines. Murine studies also support the
hypothesis that Th1 cells are involved in protection, while
Th2 cells are involved in persistence and disease [26]. NK
cell production of interferon (IFN-γ) drives CD4T cells
towardstheTh1-IFN-γ producingphenotypethenleadingto
protection of infection. T-cell production of IFN-γ may also
inhibit intracellular chlamydial replication possibly inducing
a persistent infection. In fact, IFN-γ has been shown to delay
the cycle of Chlamydia so that the reticulate bodies persist
longer and could result in persistent, unapparent infection
and then contribute to immunopathogenesis [1].
In many studies [5, 27], it has been reported that the
resolutionofgenitalchlamydialinfectionisdependentonthe
inﬂux of IFN-γ producing CD4+ Th1 cells. These cells, that
are essential for the host defense, may also cause collateral
tissue damage and scarring [28]. Production of IFN-γ by
peripheral blood mononuclear cells (PBMCs) stimulated
with Ct-hsp60 strongly correlates with protection against
ongoing Ct infections although there is no information
regarding the development of late sequelae. Deﬁning the
speciﬁc responses that promote tissue damage and diﬀeren-
tiating them from those that lead to benign resolution of
infection is an important ongoing research goal.
In the presence of chronic or repeated infections, CD4
and CD8 cells inﬁltrate in larger numbers than neutrophils,
B cells and plasmacells do, and this recurrent inﬂammatory
response is eventually responsible for the ultimate patholog-
ical eﬀects in Ct infections.
The acute inﬂammatory response occurs, at the same
extent, in both initial and repeated infections, whereas T-
cells are predominant in the latter ones. In the repeated
infections, a lymphoid follicle containing all kind of cells
(B-cells, macrophages, neutrophils, and T cells) is formed
in the deep stroma. The more rapid and intense response
observed in the reinfections depends on the massive calls
of chronic inﬂammatory leucocytes, but, in this context, the
recruitedinﬁltratecontainsChlamydia-speciﬁcimmunecells
that ampliﬁes the response promoting further tissue scarring
[4–6, 8–29].
The immune response in human females during C. tra-
chomatis infection of the cervical epithelial cells is reported
in Figure 2.
3.3. Regulatory T-Cells (Tregs). Regulatory T-cells (Tregs),
the action of which is to downregulate immunity, have
been extensively studied in the pathogenesis of allergy,
autoimmunity, and inﬂammatory diseases; recently, many
researchers have been focused on their role during Ct
infection [30]. Natural Treg cells, expressing CD4+CD25+
and the transcription factor FOXP3 (forkhead box P3), are
selected in the thymus and move to the periphery. In the
periphery, CD4+ T cells can be induced to become Tregs
(called adaptative Treg cells), and hence secrete IL-10 or
TGF-β (transforming growth factor β) or both. High levels
of IL-2 induce the proliferation of Tregs and also contribute
to their eﬃciency and ﬁtness. Furthermore, it is known
that bacterial heat-shock protein 60 (hsp60) and ﬂagellin
enhance the suppressive functions of CD4+CD25+ T-cells
through the production of IL-10 and TGF-β.T r e gc e l l s
inhibit the function of both Th1 and Th2 CD4+ T cells and
their production of cytokines; additionally, their role is to
suppresstheCD8+Tcellactivity.Inthisway,theyreducetheISRN Obstetrics and Gynecology 5
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Figure 2: Modiﬁed from Agrawal et al. 2009 [1] (see text for details).
Table 2: Host factors and cellular immune responses associated with susceptibility or protection from infection and/or diseases.
Host factor or response Association References
IFN-γ production by PBMCs stimulated with Ct-hsp60 Protection from incident C. trachomatis infection [34]
Low PBMC IFN-γ and high IL-10 responses to Ct-hsp60 Increased risk of C. trachomatis infection and PID [7]
Low CD4 cell count in HIV-infected women Increased risk of PID [35]
Neutrophils and neutrophil defensin levels in cervical
secretions
Positive correlation with histologic endometritis in girls
with clinical PID [36]
IL-10 promoter polymorphism (IL-10-1082AA); IL-2
reduction Increased risk of infertility [37]
Cervical cell production of IL-1β,I L - 6 ,I L - 8 ,a n dI L - 1 0i n
response to stimulation with Chlamydia trachomatis EBs
Positive correlation with infertility in C.
trachomatis-seropositive patients [11]
Cervical cell production of IFN-γ and IL-12 in response to
stimulation with Chlamydia trachomatis EBs
Positive correlation with fertility in C.
trachomatis-seropositive patients [1]
Legenda: Ct-hsp60: Chlamydia trachomatis heat-shock protein 60; EBs: elementary bodies; IFN: interferon; PID: pelvic inﬂammatory disease; PBMCs:
peripheral blood mononuclear cells.6 ISRN Obstetrics and Gynecology
amount of mucosa inﬂammation but contribute to bacterial
persistence and colonization of the genital tract [5, 23].
4.Host ImmuneResponse andSusceptibility
Host immune factors are considered the most important
determinants of the patients variability in the course and
outcome of the disease with the production of pro- or anti-
inﬂammatory cytokines.
Indeed, not only the characteristics of the pathogen, but
also host genetics play an important role in determining
susceptibility to infections and severity of illness.
Immunogenetic studies in innate immunity can explain
individual diﬀerences in response to infection [31]. In fact, a
low immune response may result in a suitable environment
forpathogencolonization,whileastrongresponsecouldlead
to excessive inﬂammation and tissue damage. In such a way,
the modulation of the host response to infection results to
be of a great importance for the disease course. TLR agonists
or antagonists are under clinical studies for the treatment of
cancer and allergies and for the preparation of vaccines and
vaccine adjuvants [32].
As far as the outcome of the disease is concerned,
genetic studies evaluate the role of genetic variations in
immunologically important hostgenesthatcanexplain indi-
vidual diﬀerences in response to infection. Single nucleotide
polymorphisms (SNPs), in which one nucleotide has been
substituted or deleted or inserted, are included in the ﬁeld
of immunogenetic research. The interpatient variability is
correlated with infections, and the polymorphisms may
have important biological consequences either directly or
indirectly. The importance of genetic variations in genes
encoding TLRs and NODs as potential risk factors for
Ct disease depends on the fact that they are involved in
the ﬁrst step of infection by recognizing adequately the
speciﬁc pathogen among others. TLR2, TLR4, and TLR9
being expressed in the genital human female tract have
an important role in the recognition of Ct-PAMPs in
infected women. When genetic variations occur in TLR
genes, aberrant or dysfunctional receptors may result in
an inadequate recognition of Ct and in an increased risk
of persistence. Therefore, genetic polymorphisms, which
are diﬀerent and variable among people, can modulate the
progress of the disease and determine the susceptibility to Ct
genital tract infections. It has been reported that TLR genetic
variation may act in both a damaging way (as it is generally
supported) and a protective way [33].
NOD genetic variations may be also risk factors for
the inadequate recognition and persistence of Ct and,
furthermore, could increase the possibility of an aberrant
immune response.
4.1. Production of Chemokines and Host Factors. An associa-
tion between speciﬁc host immune response and susceptibil-
ity to chlamydial infection has been documented [5].
IFN-γ secretion by mucosal cells is found to be signiﬁ-
cantly higher after stimulation with both Ct-hsp60 and Ct-
hsp10 and is correlated with protection against incident C.
trachomatis infection [34]. CD4 cells result in an increase
in cervical mucosa of fertile women whereas CD8 cells are
found to be only slightly increased.
Low peripheral blood mononuclear cells (PBMCs) IFN-
γ and high IL-10 responses to Ct-hsp60 are markers for
increased risk of chlamydial infection and PID [7]. In
seropositive women, a marked decrease of CD4 T cells leads
to a strong risk of PID [35].
Neutrophils and neutrophil defensin levels in cervical
secretionscorrelatewithendometritisinwomenwithclinical
PID [36]. Reduced IL-2 concentrations in endocervical
secretions are strictly related to tubal infertility as well
as IL-10 promoter polymorphism (IL-10-1082AA) [37].
Signiﬁcantly high levels of IL-1 β, IL-6, IL-8, and IL-10 are
observed in seropositive patients with fertility disorders [11].
IFN-γ and IL-12 are positively correlated with fertility in Ct-
seropositive patients [1]( Table 2).
5. Ct-hsp60
Chlamydia heat shock protein 60 (Ct-hsp60) has been
investigated as a potential antigen responsible for induction
of delayed type hypersensitivity-induced disease. Ct-hsp60
reveals a protective role for vaccination in guinea pig
[38]. Detection of elevated titers of antibody to Ct-hsp60
has been found in the subjects with severe disease and
mainly in chronic or repeated infections [8]. Ct-hsp60 alone
can activate endothelial cells and macrophages to produce
adhesion factors and proinﬂammatory cytokines and to
stimulate the secretion of TNF-α. TLRs bind to Ct-hsp60
and induce signals for the production of cytokines and
chemokines that begin the inﬂammatory chronic response
[4]. Ct-hsp60 is synthesized during infection and is released
in the bloodstream. As a consequence, immune cells will
produce anti-Ct-hsp60 antibodies.
Hsp60 is an ubiquitous molecule with multiple roles: it
is a highly conserved protein and shares numerous identical
amino acids between eukaryotes and prokaryotes. This
implies that there are common antigenic sites (epitopes)
between humans and Chlamydiae able to elicit, in infected
individuals, cross-reactive antibodies which react, other than
with microbial products, also with analogous human anti-
gens (autoimmunity). This pathology is detected in autoim-
mune diseases such as arthritis, multiple sclerosis, diabetes,
atherosclerosis, vasculitis, and thyroiditis [39–41]. Hsp60 is
a group I chaperonin, generally mitochondrial molecule that
is often associated with its cochaperonin hsp10: hsp60 and
hsp10 form a complex of a double ring shape [9]. Upon cell
stress and during carcinogenesis, the chaperones are found
in the cell surface (sf-hsp60) and/or are secreted from cells
into the extracellular space and circulation. The sf-hsp60 can
stimulate the autoimmune aggression toward stressed cells
and induce the disease development [9]. During persistent
infections, Ct produces a large quantity of hsp60 implied
in autoimmune disorders [42]. The cross-reactive eﬀects are
perpetuated and possibly ampliﬁed in human infections due
to the fact that human chaperonins are present not only in
the cells but also outside them attached to the cell membrane
orincirculation.Inthiscase,theriskofautoimmunediseases
is increased [43]. Elevated titers of antibodies anti-Ct-hsp60ISRN Obstetrics and Gynecology 7
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Figure 3: Modiﬁed from Cappello et al. 2009 [9]. Potential eﬀects of anti-Ct-hsp60 antibodies. These antibodies recognize surface-hsp60
onstressed or tumor cells, and consequently, they can lead to either damage and persistence of infection or cell lysis producing a regression
of certaintypes of cancer. Immunocomplexes (Ct-hsp60 and anti-Ct-hsp60) can cause disease if they form deposits in the renal glomerulus.
are recognized as a marker of persistent infection. In fact,
a strict correlation between the detection of Ab-Ct-hsp60
and previous chlamydial infection as well as between Ab-
Ct-hsp60 and elevated serum Ig G or Ig A levels has been
demonstrated [8].
The pathological lesions due to the presence of immuno-
precipitates (immunocomplexes formed by anti-Ct-hsp60
antibodies and Ct-hsp60) may furtherly worsen the course
of disease forming deposits in several anatomic allocations,
such as glomerular basal membrane.
Hsp60mayalsobeelevatedintumorsandcardiovascular
diseases [44, 45]: in fact superﬁcial (sf) hsp60 occurs in the
cell membrane of some tumors being a target for antibodies.
If hsp60 is present on the surface of malignant cells, as it
happens in some types of cancer, cells with this antigen can
be destroyed by anti-hsp60 antibody then leading to damage
of the tumor. Following these aﬃrmations, anti-Ct-hsp60
antibodies are prone either to cause a long lasting infection
ortobeprotectiveagainstcertaintumorsstoppingthecancer
progression [9]( Figure 3).
6. Conclusions
Ct immunopathogenesis is a challenge, because the complex
mechanism that is on the basis of the interaction between
host and microorganism is not fully understood: in fact, host
immune response and microorganism virulence strongly
aﬀect the disease outcome.
The host immune response does not eliminate the
pathogen but in contrast is able to worsen the clinical course
of the infection [3–6, 23]; on the other hand, host gene
polymorphisms with their anti- or proinﬂammatory eﬀects
address the outcome of Chlamydia trachomatis disease.
GeneticvariationinTLRandNODgenesmayaﬀectreceptor
function, leading to an inadequate recognition of Ct, to
an unsuitable immune response and consequently leading
to an increased risk of persistence and late sequelae [3].
The determination of genetic polymorphisms may serve to
identify persons at high risk of illness development and in
need of increased levels of screening and treatment.
The infected nonimmune host cells (epithelial cells)
are the ﬁrst line of human defense. They are involved
in the inﬂammatory response to Chlamydia. In fact, they
not only induce the inﬂux of inﬂammatory cells, but also
release tissue-damaging molecules. Ct infection stimulates
the production of several cytokines such as IL-2, IL-
6, IL-8, IL-10, IL1b, TNF-a, GM-CSF, and IFN-γ which
account for chronic and intense inﬂammation and for the
promotionofcellularproliferation,tissuedamage,andtissue
remodelling and scarring [4]. CD4 Th1-IFN-γ producing
cellsarestronglyinvolved intheprotectionfromCt infection
and disease, whereas the role of CD8 Th1-cell population
in the fertility disorders is not well deﬁned. Hsp60 is an
ubiquitous, multifaceted, versatile molecule, which plays a
crucial role in Ct pathogenesis. During persistent infections,
the pathogen produces a large quantity of hsp60, implied in
the pathogenesis of the genital tract and in the autoimmune
disorders. The physician should always consider the various
roles of hsp60 and anti-hsp60 antibodies and measure them
in all cases with suspected or demonstrated autoimmune
manifestations. In any case, conclusions about the role
of anti-hsp60 antibodies in the onset and progression of8 ISRN Obstetrics and Gynecology
disease must be taken as provisory and with need of further
investigations. In fact, if, on one side, the anti-Ct-hsp60 are
damaging and are likely to cause long-lasting disease, on the
other, they can protect from some kinds of cancer.
Further problems that should be deeply examined in Ct
infections concern the possible link that may exist between
more virulent strains and antibiotic resistance that is known
to be a crucial drawback in this disease treatment.
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